Women are three times more likely to have thyroid nodules or thyroid cancer, compared to men. Women are also five to ten ...

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation ...

Inhalable microplastics are a subset of airborne microplastics. While airborne microplastics are typically less than 5 mm in ...

Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...

The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.

Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for Fourth-Quarter 2025, with ...

Patients with cancer are more likely to die from cardiovascular diseases, according to a study. The study, published in the ...

Though it has long been recognized that the liver exhibits remarkable immune tolerance, the underlying mechanisms driving ...

A new study suggests that one of the most common diabetes treatments may speed type 2 diabetes progression by causing insulin-producing cells to lose their functional identity. Sulphonylureas have bee ...

Driven Care for Young Women with Breast Cancer DENVER, CO, UNITED STATES, January 1, 2026 /EINPresswire.com/ — The Breast Cancer in Young Women Foundation (BCYW Foundation) is pleased to begin the new ...

Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...